Use fundamental data analysis to confirm all available indicators of Virtus LifeSci Biotech to find out if markets are presently mispricing the entity. We found ten available drivers for Virtus LifeSci Biotech Products ETF which can be compared to its competition. Please use Virtus LifeSci Price to Earning, Total Asset as well as the relationship between Total Asset and Equity Positions Weight to make a decision on weather Virtus LifeSci Biotech is priced fairly. Use Virtus LifeSci to protect your portfolios against small markets fluctuations. The etf experiences normal downward trend and little activity. Check odds of Virtus LifeSci to be traded at $39.5 in 30 days.
Virtus LifeSci Company Summary
Virtus LifeSci competes with Health Care, Vanguard Health, iShares Nasdaq, SPDR SP, and iShares US. The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Virtus LifeSci is traded on Archipelago Exchange in USA.
Virtus LifeSci Price to Sales vs Net Asset
Virtus LifeSci Biotech Products ETF is third largest ETF in price to sales as compared to similar ETFs. It is rated below average in net asset as compared to similar ETFs making up about 4,364,286 of Net Asset per Price to Sales.
|Price to Sales ( times )|
Virtus LifeSci Biotech Systematic Risk